Pharmafile Logo
Pharmafocus logo
Advanced Search
limbix

SparkRx depression therapeutic shown to cut depression symptoms in adolescents

October 11, 2021
Sales and Marketing FDA, Limbix, SparkRx

A new digital therapeutic available for use without prescription under the FDA’s emergency guidance for digital health devices has shown …

News

NICE approves treatment for rheumatoid arthritis

October 11, 2021
Sales and Marketing

NICE has issued a positive final appraisal document recommending upadacitinib, a once-daily oral therapy, for people with previously treated moderate …

News

Two Indian drugmakers to discontinue MSD’s molnupiravir

October 8, 2021
Medical Communications

AuroBindo Pharma Ltd and MSD Laboratories plan to end their respective trials of MSD’s experimental antiviral drug molnupiravir in moderate …

News
samsung_bioepis

Samsung Biologics partners with Enzolytics Inc for antibody therapies

October 8, 2021
Medical Communications

Leading manufacturing organisation Samsung Biologics, alongside drug development company Enzolytics, have announced the signing of a strategic CDMO partnership agreement. …

News

Talem Therapeutics and Pierre Fabre to form antibody research collaboration

October 8, 2021
Medical Communications

Talem Therapeutics, subsidiary of Immunoprecise Antibodies Ltd (IPA), and the Pierre Fabre pharmaceutical group have announced a multi-target research collaboration, …

News
moderna_norwood_plant

Finland joins Sweden and Denmark to limit use of Moderna vaccine

October 8, 2021
Medical Communications

On Thursday, Finland became the latest country to suspend the use of Moderna’s COVID vaccine on younger males, amid reports …

News

UN Secretary General makes $8 billion plea to vaccinate 40% of world in 2021

October 8, 2021
Medical Communications

UN Secretary-General, Antonio Guterres, appealed on Thursday for $8 billion to help equitably vaccinate 40% of people in all countries …

News

Women and children most impacted by mental health during pandemic

October 7, 2021
Business Services

The Headway 2023 Mental Health Index has revealed that the pandemic has taken a significant toll on the mental health …

News

Incyte trial reveals encouraging results for patients with vitiligo

October 7, 2021
Business Services

Incyte has announced full results from its Phase III TRuE-V Program, evaluating Ruxolitinib Cream in patients with vitiligo. Treatment with …

News

Nobel Prize awarded to molecule construction champions

October 7, 2021
Business Services

Benjamin List and David MacMillan have been awarded the Nobel prize in chemistry, for their construction of a tool used …

News
pfizer

Pfizer enlists entire town in Brazil for COVID study

October 7, 2021
Research and Development

An entire town in Brazil has been enrolled by Pfizer to study the transmission of the coronavirus within a vaccinated …

News

WHO rolls out GSK’s malaria vaccine in Africa

October 7, 2021
Medical Communications, Research and Development

The WHO has given the go-ahead for the mass roll out of a malaria vaccine for children, in a historic …

News

Janssen’s bowel disease drug shown to be safe for use in older patients

October 6, 2021
Research and Development

The Janssen Pharmaceutical Companies of J&J have announced that STELARA® (ustekinumab) has a high safety profile in older patients across …

News

UroGen Pharma shows positive results for bladder cancer patients

October 6, 2021
Research and Development

UroGen Pharma Ltd has published results from the Phase IIb OPTIMA II trial, a single-arm trial studying UGN-102 (mitomycin) as …

News

Third dose of COVID-19 vaccine approved for immunocompromised over 12

October 6, 2021
Research and Development

The EMA have authorised the third dose of the Moderna COVID-19 vaccine (Spikevax), to be administered on immunocompromised individuals aged …

News

Merck secures Singapore deal for COVID antiviral pill

October 6, 2021
Medical Communications, Research and Development

Merck announced on Wednesday a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID-19 …

News

Bayer wins first court case in Roundup child cancer battle

October 6, 2021
Medical Communications, Research and Development

Bayer AG has won its first court case over claims its Roundup weed killer causes cancer after a California jury …

News

Transgene and BioInvent to present oncolytic virus data at SITC 2021

October 5, 2021
Manufacturing and Production

Biotech companies Transgene and BioInvent International AB (BioInvent), have announced that they will present preclinical data on their novel dual …

News
6206572255_438e12011d_c

AstraZeneca requests emergency authorisation for COVID-19 drug

October 5, 2021
Manufacturing and Production

AstraZeneca has submitted an FDA request for Emergency Use Authorisation (EUA) for AZD7442, a long-acting antibody combination (LAAB) for the …

News

Kintor begins Phase III trial of proxalutamide for COVID patients in US

October 5, 2021
Manufacturing and Production

Chinese clinical-stage drug developer, Kintor Pharmaceutical Ltd, has announced the initiation of the Phase III clinical trial of proxalutamide for …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025